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Abstract Despite the well-established observation that sub-
stitution of saturated fats for carbohydrates or unsaturated fats
increases low-density lipoprotein (LDL) cholesterol in humans
and animal models, the relationship of saturated fat intake to
risk for atherosclerotic cardiovascular disease in humans
remains controversial. A critical question is what macronutri-
ent should be used to replace saturated fat. Substituting
polyunsaturated fat for saturated fat reduces LDL cholesterol
and the total cholesterol to high-density lipoprotein cholesterol
ratio. However, replacement of saturated fat by carbohydrates,
particularly refined carbohydrates and added sugars, increases
levels of triglyceride and small LDL particles and reduces
high-density lipoprotein cholesterol, effects that are of partic-
ular concern in the context of the increased prevalence of
obesity and insulin resistance. Epidemiologic studies and
randomized clinical trials have provided consistent evidence
that replacing saturated fat with polyunsaturated fat, but not
carbohydrates, is beneficial for coronary heart disease.
Therefore, dietary recommendations should emphasize substi-
tution of polyunsaturated fat and minimally processed grains
for saturated fat.
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Introduction
Dietary saturated fat intake has been shown to increase low-
density lipoprotein (LDL) cholesterol, and therefore has
been associated with increased risk of cardiovascular
disease (CVD). This evidence, coupled with inferences
from epidemiologic studies and clinical trials, has led to
longstanding public health recommendations for limiting
saturated fat intake as a means of preventing CVD.
However, the relationship between saturated fat and CVD
risk remains controversial, due at least in part to the
intrinsic limitations of clinical studies that have evaluated
this relationship.
Prospective epidemiologic studies have been limited by
a reliance on nutritional assessment methods of varying
accuracy, the assumption that diets remain the same over
the long term, and incomplete adjustments for relevant
confounders, including other nutrients. Randomized clinical
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trials testing the effects of reduced saturated fat on CVD
risk have generally replaced saturated fat with polyunsatu-
rated fat, monounsaturated fat, or carbohydrate. Therefore,
any assumed benefit of reducing saturated fat as gleaned
from clinical trial evaluations is complicated by concomi-
tant increases in replacement nutrients.
This article reviews the evidence for adverse effects of
saturated fat on lipids and CVD risk and examines the most
recent developments that suggest a re-evaluation of the
longstanding diet–heart hypothesis (ie, the presumed link of
saturated fat with CVD) is timely and necessary. We
suggest that the overall evidence from clinical trial and
epidemiologic data is most consistent with a protective
effect of higher intakes of polyunsaturated fats, with a
corresponding increase in the polyunsaturated fat to
saturated fat ratio. On the other hand, to the extent that
reduction in saturated fat is achieved by increased con-
sumption of refined carbohydrates, there can be a delete-
rious impact on CVD risk due to adverse effects on
components of metabolic syndrome [1].
Effects of Saturated Fat on Plasma Lipids
and Lipoproteins
In humans, saturated fat intake increases LDL cholesterol in
comparison with all nutrients except trans fats [2•].
Because saturated fat also increases high-density lipopro-
tein (HDL) cholesterol, the total cholesterol (TC) to HDL
cholesterol ratio (a risk marker for CVD) is not altered.
LDL particles are heterogeneous in size, density, and
composition. Smaller and denser LDL particles in particular
have been strongly associated with atherosclerotic CVD
[3]. Changes in dietary saturated fat have been associated
with changes in concentrations of larger, more buoyant
particles [4]. In the context of a lower-carbohydrate diet
(26% of total energy), high saturated fat content (15% of
energy) provided from dairy products was associated with
increased concentrations of large and medium LDL
particles, but not small LDL particles, compared with a
diet lower in saturated fat (8% of energy) [5].
Studies in animals have shown that saturated fats increase
LDL cholesterol by inhibiting LDL receptor activity and
enhancing apolipoprotein (apo)B-containing lipoprotein pro-
duction [6]. This LDL cholesterol–raising effect of saturated
fatty acids has been shown to depend on the level of dietary
cholesterol, such that the greatest increases in plasma LDL
concentrations were observed at the highest levels of dietary
cholesterol [6]. In the absence of dietary cholesterol, and
when polyunsaturated fatty acid intake is adequate (5%–10%
of energy), saturated fat has been observed to have a
negligible effect on LDL clearance in nonhuman primates,
and the lipoprotein profile remains relatively normal
(LDL<90 mg/dL) [7]. When individuals or animals are fed
excessive calories and dietary cholesterol, specific saturated
fatty acids (particularly palmitic acid) can contribute to
decreased LDL receptor activity [7]. Nonetheless, LDL
receptor downregulation by dietary cholesterol greatly
exceeds that by saturated fatty acids [7].
In line with data in humans [8], feeding of dietary
monounsaturated fat to nonhuman primates reduced LDL
without lowering HDL, and in comparison to saturated and
polyunsaturated fat, provided the lowest LDL to HDL ratio
[9•]. On the other hand, replacement of some of the saturated
fat with monounsaturated fat was associated with an even
greater enrichment of LDL particles with cholesteryl oleate,
a change in LDL particle composition that has been shown
to confer atherogenicity [9•]. However, caution is needed in
applying the results from animal experiments to humans.
Different saturated fatty acids have varying effects on
LDL cholesterol, HDL cholesterol, and the TC:HDL
cholesterol ratio when they replace carbohydrate [10]. The
longer chain stearic acid (18:0) has been shown to have no
effect on LDL or HDL cholesterol or the TC:HDL
cholesterol ratio, and saturated fatty acids of shorter length
have been shown to have a greater LDL cholesterol–raising
effect, such that lauric acid (12:0) raised LDL cholesterol
the most, followed by myristic (14:0) and palmitic (16:0)
acids. Lauric acid also increased HDL cholesterol most
significantly, and it did this disproportionately to TC, so
that its replacement of carbohydrate actually led to a
significant decrease in the TC:HDL cholesterol ratio [10].
It has been demonstrated that the expected increases in LDL
cholesterol with high saturated fat intake can be attenuated by
reductions in levels of small, dense LDL particles resulting
from reduced dietary carbohydrate content and/or weight loss
[5, 11]. The influence of weight reduction is illustrated by
results of a 12-month study that showed no significant
differences in LDL cholesterol change after weight loss
among diets with a wide range of saturated fat content [12].
There exists considerable inter-individual variation in the
response to dietary saturated fat. The ability of saturated
fats to raise LDL cholesterol is enhanced by increased
intake of dietary cholesterol as well as baseline LDL
cholesterol concentrations [2•]. Intrinsic differences in the
regulation of lipid metabolism may partly explain the
heterogeneity of responses to dietary saturated fat. In fact,
an association of the apoE4 allele with a greater LDL
response to saturated fat has been reported in a number of
studies, although this effect is confounded by the relationship
of apoE4 to baseline LDL levels. Studies have also shown that
other factors, including obesity, insulin resistance, hyper-
triglyceridemia, and female gender, may lead to weaker LDL
cholesterol–raising effects of dietary saturated fat [2•].
Finally, the effects of saturated fat can be modulated by the
foods in which they are contained [13]. Cheeses may have
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smaller effects on LDL cholesterol concentrations than butter,
and fermented dairy foods, such as yogurt, have been
associated with LDL reductions [13]. Recently, adipose tissue
conjugated linoleic acid (CLA) was found to be inversely
associated with risk of myocardial infarction in a case-control
study and appeared to offset the strong risk observed with
saturated fat [14]. CLA can be found in meaningful
concentrations in the milk of pasture-fed cows [14]. However,
the potential cardiovascular benefits of CLA need confirma-
tion from prospective cohort studies and intervention trials.
Lipid Effects of Reducing Saturated Fat
Studies that evaluate the effects of saturated fat on lipids
and lipoproteins under weight-stable conditions inherently
test the replacement of saturated fat with other nutrients.
Replacement of Saturated Fat with Polyunsaturated Fat
Replacement of saturated fat with polyunsaturated fat has
been shown to decrease TC and LDL cholesterol by lowering
LDL cholesterol production rates and/or increasing LDL
clearance rates [2•]. Although replacement of saturated fat
with polyunsaturated fat has been shown to decrease HDL
cholesterol, it decreases LDL cholesterol even more sub-
stantially; thus, the HDL:LDL ratio is increased [15] and the
TC:HDL cholesterol ratio is decreased [10]. Of note, some
studies have suggested that saturated fat may increase LDL
cholesterol only if the polyunsaturated fat intake falls below
a threshold level; specifically, the availability of linoleic acid
may determine the cholesterolemic effects of other fatty
acids [16]. The ratio of polyunsaturated fat to saturated fat
was recently shown to be inversely associated with LDL
cholesterol and TC but not with hemoglobin A1c, blood
pressure, serum triglycerides, and HDL cholesterol in 1004
Japanese men and women [17]. Overall, through its effects
on plasma lipoproteins (ie, lowering of LDL cholesterol,
minimal effect on HDL cholesterol, and lowering of the TC:
HDL cholesterol ratio), the replacement of saturated fat with
polyunsaturated fat has been projected to modestly lower
coronary heart disease risk (by about 10% for each 5%
energy substitution) [18•]. However, these benefits are likely
to be underestimated because polyunsaturated fats can have
other benefits beyond cholesterol, including improving
insulin sensitivity and reducing inflammation [19].
Replacement of Saturated Fat with Monounsaturated Fat
Replacement of saturated fat with monounsaturated fat has
also been associated with decreased total, LDL, and HDL
cholesterol, although the magnitude of reduction for each of
these lipids is slightly less than when polyunsaturated fats
are the replacement nutrient [15].
Replacement of Saturated Fat with Carbohydrate
Replacement of saturated fat with carbohydrate results in
lower total, LDL, and HDL cholesterol but also increases
triglycerides [2•]. The magnitude of reduction of HDL
cholesterol is comparable to the reduction in TC, so that the
TC:HDL cholesterol ratio is, on average, not changed [10].
Although no effect on plasma lipid levels of exchanging
7% to 8% fat for complex carbohydrates was found in a
large-scale dietary intervention [20], these null results were
most likely attributable to the failure of the study
participants to adhere to the study diet [21]. In a study of
52 men and 33 women with baseline dyslipidemia
participating in a three-period, 7-week, randomized, cross-
over dietary intervention study, monounsaturated fat was
shown to be the preferred replacement for saturated fat [22].
Although replacement of 7% saturated fat with both
monounsaturated fat and carbohydrate effectively lowered
LDL cholesterol, replacement with monounsaturated fat
was associated with lesser reductions in HDL cholesterol
and lesser increases in lipoprotein(a) and triglyceride
concentrations [22].
High Carbohydrate Intake Contributes to Dyslipidemia
Elevated triglycerides, reduced HDL cholesterol concentra-
tions, and increased concentrations of small, dense LDL
particles characterize the dyslipidemia that is part of a
metabolic profile considered to be a major contributor to
increased CVD risk. Both insulin resistance and high
carbohydrate intakes have been shown to contribute to this
dyslipidemia, and refined carbohydrates, in particular, can raise
triglyceride and lower HDL cholesterol concentrations [23]. Of
interest, reductions in dietary carbohydrate, even in the
context of a diet high in saturated fat, have been associated
with reduced concentrations of small, dense LDL [5].
The type of carbohydrate consumed can affect blood
lipid profiles. Using the glycemic index (GI) as a
classification system that rates dietary carbohydrates by
their ability to increase postprandial blood glucose levels,
the consumption of lower-GI foods has been associated
with lower triglycerides and higher HDL cholesterol [24].
Substituting low-GI foods for high-GI foods may lower
triglyceride concentrations by 15% to 25% [25]. There is
also considerable evidence that high intake of added sugars
[26], and fructose in particular [27], adversely affects all
components of atherogenic dyslipidemia. Most recently, an
evaluation of data from 6113 adults participating in the
National Health and Nutrition Examination Survey
(NHANES) showed a positive correlation between added
sugars and dyslipidemia [28]; the minimization of sugars as
a component of the American diet would be expected to
improve these diet-induced abnormal lipid profiles.
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Effects of Saturated Fat on Coronary Heart Disease
Animal Studies
Assessment of the effects of dietary saturated fat on athero-
sclerosis has been studied in various animal models [9•].
Interestingly, in nonhuman cholesterol-fed primates, despite
the favorable lipid profiles conferred by monounsaturated fat
feeding compared with saturated fat feeding, both diets led to
equivalent amounts of atherosclerosis, whereas similar intake
of omega-6 polyunsaturated fat afforded atherosclerosis
protection [9•]. Similarly, more atherosclerosis was observed
in LDL knockout mice fed monounsaturated fats compared
with mice fed either polyunsaturated or saturated fat [29].
Clinical Trials
Clinical trials designed to evaluate dietary effects on CVD risk
have reduced saturated fat by increasing the consumption of a
replacement nutrient. A recent meta-analysis of eight clinical
studies that replaced saturated fat with polyunsaturated fat (n=
13,614 participants with 1042 CHD events) estimated a
coronary heart disease CHD risk reduction of about 10% for
each 5% energy replacement of saturated fat with polyun-
saturated fat, an effect comparable to that predicted from the
effects of the intervention on TC:HDL cholesterol ratio [30•].
In contrast, replacement of saturated fat with carbohy-
drate was not associated with improvements in CHD risk in
the Women’s Health Initiative, a dietary intervention
originally designed to test the effects of a low-fat
intervention on cancer and cardiovascular risk [31, 32].
The 8-year study effectively lowered total fat as well as
saturated fat intake, although not to the degree that the
investigators had intended (the difference in reported fat
intake was only 8% in comparison to the desired 14%), thus
casting doubt on dietary compliance [21, 31]. Furthermore,
the dietary intervention involved a change in overall dietary
pattern, making it difficult to attribute the null effect on
CHD risk to changes in a specific nutrient.
Observational and Prospective Epidemiologic Studies
Although early epidemiologic studies linking saturated fat
with blood cholesterol and blood cholesterol with CHD
were important in defining a conceptual model of etiology
for CVD [33, 34], they were a simplification of the
complex relationship of nutrients to disease outcomes.
These studies were based on aggregated data and did not
adjust for potential confounders (eg, trans fatty acids,
polyunsaturated fatty acids, and high-GI carbohydrates),
some of which have only more recently come to be known
as relevant in modulating CVD risk.
Prospective cohort studies are designed to enable the
evaluation of potential baseline disease determinants with
future disease outcomes by following a cohort of study
participants over a period of time. Large, prospective
epidemiologic studies have the advantage of being able to
adjust for co-variates, so that the effects of a specific
nutrient can be assessed. However, caveats to such studies
include the reliance on nutritional assessment methods with
varying accuracy and the assumption that diets remain
similar over the long term.
Our recent meta-analysis summarized data related to
saturated fat and CVD from 21 prospective epidemiologic
studies that included 347,747 men and women [35•].
During 5 to 23 years of follow-up, 11,006 people developed
CHD or stroke. Intake of saturated fat was not significantly
associated with an increased risk of CHD, stroke, or CVD
(RR=1.07; 95% CI, 0.96–1.19; P=0.22) in adjusted logistic
regression models. Because the inclusion of serum choles-
terol among the adjusted co-variates may attenuate the
relationship of saturated fat with CVD, a subgroup analysis
among 15 studies that did not include serum cholesterol in
their models was conducted [36–50]. The results from this
secondary analysis (RR=1.02; 95% CI, 0.86–1.19) con-
firmed the lack of association of saturated fat with CVD
observed in the larger study. These findings are consistent
with another systematic review that showed a nonsignifi-
cant association of saturated fat with CVD [51].
The interpretation of these data is complicated by the fact
that most epidemiologic studies that were included in the
meta-analysis did not explicitly model the effects of nutrient
substitution. However, because saturated and total fat are most
commonly replaced with carbohydrates, the lack of associa-
tion between saturated fat and risk of CHD observed in
epidemiologic studies can be interpreted as the lack of benefit
of substitution of carbohydrates for saturated fat.
Although it has been observed that saturated fat may be
associated with CHD or CVD in specific age and gender
subgroups [40, 41], the data to support these hypotheses are
limited [35•]. There have also been several reports of
inverse associations of saturated fat with CVD, specifically,
with stroke [50, 52] and coronary atherosclerosis progres-
sion in postmenopausal women [53]. However, a significant
inverse relationship of saturated fat with stroke was not
supported in a meta-analysis of eight such studies [35•].
Finally, although it has been suggested that the association
of saturated fat with CHD may be specific to “hard” (ie,
fatal) versus “soft” (ie, nonfatal) end points [54], our
analysis of the studies that considered fatal CHD as the
outcome variable (n=7) yielded a nonsignificant pooled RR
estimate of 1.18 (95% CI, 0.99–1.42) (random effects
model; P for heterogeneity=0.02; test for overall effect=
0.07). Because the use of fatal CHD as the outcome
involves both incidence and survival of the condition, it is
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difficult to separate the role of saturated fat in the
development and prognosis of CHD.
Modulation by Replacement Nutrients
A pooled analysis of 11 cohort studies (n=344,696 persons)
used a standardized statistical analysis protocol to explicitly
examine replacement effects of individual nutrients. The
authors found that replacement of saturated fat with
polyunsaturated fat, but not carbohydrate or monounsatu-
rated fat, was associated with decreased risk of CHD [55•].
Indeed, the polyunsaturated fat to saturated fat ratio has
been strongly and inversely associated with CHD risk [56].
Of interest, clinical trials that have shown benefit of
reducing saturated fat have utilized diets that contained a
polyunsaturated fat to saturated fat ratio greater than 0.49
[35•], an apparent threshold above which CHD risk has
been reported to be reduced [57].
In contrast, replacement of saturated fat with carbo-
hydrate has been associated with no improvement in
CVD risk [57] and a slightly increased risk of nonfatal
myocardial infarction [55•]. In addition, a low carbohy-
drate score (indicative of higher intakes of fat and protein
and lower intakes of carbohydrate) as compared with low-
fat diets was not associated with increased risk of CHD in
women [58].
The type of carbohydrate consumed has been associated
with differences in CVD risk. A higher glycemic load,
which ranks carbohydrates based on their GI and portion
size, was associated with increased risk of CHD in the
Nurses’ Health Study [58]. More recently, a prospective
cohort study in 53,644 women showed an increased risk of
myocardial infarction when high-GI foods replaced satu-
rated fats [59•]. Only when saturated fats were replaced
with low-GI foods was there an association with a lower
risk of myocardial infarction [59•].
Other CVD Risk Factors
Although beyond the scope of this review article, there are
non-lipid CVD risk factors that may be affected by dietary
saturated fat. Relevant studies in this regard have recently
been reviewed [2•]. Briefly, although a growing body of
evidence from animal and cellular studies suggests that
dietary saturated fat may reduce insulin sensitivity [60] and
promote inflammation, clinical studies have not yielded
consistent evidence for such effects, or for adverse effects
on blood pressure, thrombosis, and vascular function [2•].
However, there is substantial epidemiologic evidence that
higher consumption of omega-6 polyunsaturated fat at the
expense of carbohydrates or saturated fat is associated with
lower risk of type 2 diabetes [60].
Conclusions
Evaluation of the association of saturated fat with lipid profiles
and CVD risk requires consideration of the replacement
nutrients. Studies in animals and humans support the concept
that replacement of saturated fats with polyunsaturated fats
results in improved lipid profiles, specifically, decreased TC
and LDL cholesterol with minimal decreases in HDL
cholesterol, as well as with decreased CVD risk. Although
replacement of saturated fats with monounsaturated fats results
in improved lipid profiles, the association of this substitution
with CVD risk is less clear. Notably, most observational
studies did not distinguish between plant and animal sources
of monounsaturated fats. Finally, replacement of saturated fat
with carbohydrates, particularly refined carbohydrates and
added sugars as has occurred over the past few decades, has
been associated with dyslipidemia and either no improvement
in CVD risk or even increased CVD risk. Given the current
epidemics of obesity and insulin resistance, reductions in the
consumption of refined carbohydrates and added sugars, in
addition to weight control and obesity prevention, should be
the prioritized public health dietary goals.
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